PostPartum2ndP: Postpartum Experience by the Second Parent

Sponsor
Université de Reims Champagne-Ardenne (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06152159
Collaborator
(none)
100
2
5
50
10

Study Details

Study Description

Brief Summary

Many studies have been performed on mothers and their postnatal experiences. Unfortunately, studies about the second parent are very rare. Second parent is yet an essential figure in the parent-child triad and a real support for the mother.

The postpartum period is a time of intense restructuring and upheaval, both physically and psychologically. Studies have shown that almost 13% of fathers suffer from depression.

Condition or Disease Intervention/Treatment Phase
  • Other: data collection

Detailed Description

The main objective is to describe the postpartum experience of the second parent.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Postpartum Experience by the Second Parent
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
The second parent of a child

The second parent of a child born since minimum 3 months and maximum 6 months.

Other: data collection
Data collection

Outcome Measures

Primary Outcome Measures

  1. Experience of the postpartum by the second parent [Day 0]

    This experience of the postpartum by the second parent will be evaluated by a Likert scale with 5 proposals: Very good experience/ Good experience/ Lived/neutral/ Bad experience/ Very bad experience

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females

  • Second parent of a child born living for at least 3 months and at most 6 months

  • Major

  • Agreeing to participate in the study

Exclusion Criteria:
  • Minors

  • Protected by law (guardianship, curatorship, safeguarding of justice)

  • Not agreeing to participate in this study

  • Parents of stillborn children

  • Refusing to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ufr Medecine Urca Reims France 51100
2 Université de Reims Champagne Ardenne Reims France 51100

Sponsors and Collaborators

  • Université de Reims Champagne-Ardenne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Reims Champagne-Ardenne
ClinicalTrials.gov Identifier:
NCT06152159
Other Study ID Numbers:
  • 2023_RIPH_018_PostPartum-2ndP
First Posted:
Nov 30, 2023
Last Update Posted:
Nov 30, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Reims Champagne-Ardenne

Study Results

No Results Posted as of Nov 30, 2023